Your browser doesn't support javascript.
loading
Migraine Risk in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Nationwide Cohort Study in South Korea.
Chung, Yeon Hak; Han, Kyung-Do; Jung, Jin Hyung; Kwon, Soonwook; Cho, Eun Bin; Park, Junhee; Shin, Dong Wook; Min, Ju-Hong.
Afiliação
  • Chung YH; Department of Neurology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea, yeonhak59@gmail.com.
  • Han KD; Department of Statistics and Actuarial Science, Soongsil University, Seoul, Republic of Korea.
  • Jung JH; Department of Biostatics, The Catholic University of Korea, Seoul, Republic of Korea.
  • Kwon S; Department of Neurology, Inha University Hospital, Incheon, Republic of Korea.
  • Cho EB; Department of Neurology, Gyeongsang Institute of Health Science, Gyeongsang National University, Jinju, Republic of Korea.
  • Park J; Department of Neurology, Gyeongsang National University Changwon Hospital, Changwon, Republic of Korea.
  • Shin DW; Department of Family Medicine and Supportive Care Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Min JH; Department of Family Medicine and Supportive Care Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Neuroepidemiology ; : 1-9, 2024 Jun 14.
Article em En | MEDLINE | ID: mdl-38880093
ABSTRACT

INTRODUCTION:

Although the relationship between migraine and multiple sclerosis (MS) has been reported, the risk of migraine in MS and neuromyelitis optica spectrum disorder (NMOSD) is unclear. Therefore, this study investigated the risk of migraine in the Korean MS and NMOSD populations.

METHODS:

This study analyzed claims data from 1,492 patients with MS and 1,551 patients with NMOSD based on diagnostic codes in the Korean National Health Insurance Service. Migraine risk was compared with a control group (matched 15 for age, sex, and comorbidities) using Cox proportional hazards analysis. Patients aged <20 years and with previous migraine were excluded.

RESULTS:

Migraine risk was higher in patients with MS (adjusted hazard ratio [aHR] 1.37; 95% confidence interval [CI] 1.15-1.62) but did not differ significantly in patients with NMOSD (aHR 1.05; 95% CI 0.87-1.27) compared to controls. No significant sex-based differences in migraine risk were observed. Patients with NMOSD showed decreasing risk with age (p for interaction = 0.040). Comorbidities like hypertension, diabetes, or dyslipidemia did not significantly alter migraine risk in either group.

CONCLUSION:

The study results revealed an increased risk of migraines in patients with MS but not in patients with NMSOD compared with matched controls.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Neuroepidemiology Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Neuroepidemiology Ano de publicação: 2024 Tipo de documento: Article